These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Moro MA; Russel RJ; Cellek S; Lizasoain I; Su Y; Darley-Usmar VM; Radomski MW; Moncada S Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1480-5. PubMed ID: 8643658 [TBL] [Abstract][Full Text] [Related]
10. Dual actions of dephostatin on the nitric oxide/cGMP-signalling pathway in porcine iliac arteries. Persson AA; Gunnarsson P; Lindström E; Grenegård M Eur J Pharmacol; 2005 Oct; 521(1-3):124-32. PubMed ID: 16182278 [TBL] [Abstract][Full Text] [Related]
11. Nitric oxide-dependent long-term potentiation is blocked by a specific inhibitor of soluble guanylyl cyclase. Boulton CL; Southam E; Garthwaite J Neuroscience; 1995 Dec; 69(3):699-703. PubMed ID: 8596640 [TBL] [Abstract][Full Text] [Related]
12. [Guanylate cyclases: physiological processes mediated by cyclic GMP]. Rivero-Vilches F; de Frutos S; Rodríguez-Puyol M; Rodríguez-Puyol D; Saura M Nefrologia; 2001; 21(3):233-9. PubMed ID: 11471303 [No Abstract] [Full Text] [Related]
13. The nitric oxide and cGMP signal transduction system: regulation and mechanism of action. Schmidt HH; Lohmann SM; Walter U Biochim Biophys Acta; 1993 Aug; 1178(2):153-75. PubMed ID: 7688574 [No Abstract] [Full Text] [Related]
15. Consideration of natriuretic peptide receptor C. Hamilton EJ; Figtree GA; Rasmussen HH Circ Res; 2011 Feb; 108(4):e4; author reply e5. PubMed ID: 21335426 [No Abstract] [Full Text] [Related]
16. [Nitric oxide. Potentiation of NO-dependent activation of soluble guanylate cyclase--(patho)physiological and pharmacotherapeutical significance]. Severina IS Biomed Khim; 2007; 53(4):385-99. PubMed ID: 18035720 [TBL] [Abstract][Full Text] [Related]
17. Involvement of NO/cGMP pathway in toluene-induced locomotor hyperactivity in female rats. Chan MH; Chien TH; Lee PY; Chen HH Psychopharmacology (Berl); 2004 Nov; 176(3-4):435-9. PubMed ID: 15118807 [TBL] [Abstract][Full Text] [Related]
18. Whole brain spheroid cultures as a model to study the development of nitric oxide synthase-guanylate cyclase signal transduction. Teunissen CE; Steinbusch HW; Markerink-van Ittersum M ; De Bruijn C ; Axer H; De Vente J Brain Res Dev Brain Res; 2000 Dec; 125(1-2):99-115. PubMed ID: 11154766 [TBL] [Abstract][Full Text] [Related]
19. Nitric oxide/cyclic GMP-mediated signal transduction. Mayer B Ann N Y Acad Sci; 1994 Sep; 733():357-64. PubMed ID: 7526764 [No Abstract] [Full Text] [Related]
20. Differential contribution of nitric oxide and cGMP to the stimulatory effects of growth hormone-releasing hormone and low-concentration somatostatin on growth hormone release from somatotrophs. Luque RM; Rodríguez-Pacheco F; Tena-Sempere M; Gracia-Navarro F; Malagón MM; Castaño JP J Neuroendocrinol; 2005 Sep; 17(9):577-82. PubMed ID: 16101896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]